The Recall Desk
SevereFDA (Drugs)·D-1763-2019·Announced 2019-08-21

Infusion Options Recalls Dacarbazine Infusions Due to Sterility Concerns

Infusion Options, Inc. is recalling Dacarbazine infusions in New York due to a lack of assurance of sterility.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.

Plain-English summary

Infusion Options, Inc. is recalling specific lots of Dacarbazine 680 mg and 675 mg in 250 ml Normal Saline. The recall is being conducted because of a lack of assurance of sterility for the affected products.

The affected products are prescription-only infusions distributed in New York. All lots within the expiration date are included in this recall.

Healthcare providers and patients should stop using the recalled products and contact Infusion Options, Inc. for further instructions.

The recalled product

Product
DACARBAZINE 680 MG in 250 ml NS; DACARBAZINE 675 MG in 250 ml NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
Manufacturer
Infusion Options, Inc.
Category
Drug — Injectable Medication
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 76 recalled by Infusion Options, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 76 products in this recall →

Related recalls

Same manufacturer · Infusion Options, Inc.

See all →

Same hazard · sterility

See all →